An anti-SARS-CoV peptide, derived from the HR2 domain of SARS-CoV S protein S2 subunit, that can bind to its HR1 domain, resulting in the inhibition of the S protein-mediated membrane fusion and hence SARS-CoV infection, has been identified [48]. Here, PROS1 is linked to severe acute respiratory syndrome.